9 Resultados para Busca Geral
Ordenado por:
Ordenado por:
RelevânciaOr hit Enter to replace sort method
- Relevância
- Data mais recente
- Data mais antiga
- Mais acessados
- Autor
- Título
Refinado por:
assunto:
Pharmacology. Drug Treatments
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
![Response to [90Yttrium-DOTA]-TOC Treatment is Associated with Long-term Survival Benefit in Metastasized Medullary Thyroid Cancer: A Phase II Clinical Trial](../images/pixel.png){kind=tracking}
Material Type: Artigo
|
|
Response to [90Yttrium-DOTA]-TOC Treatment is Associated with Long-term Survival Benefit in Metastasized Medullary Thyroid Cancer: A Phase II Clinical TrialITEN, Fabienne ; MÜLLER, Beat ; SCHINDLER, Christian ; ROCHLITZ, Christoph ; OERTLI, Daniel ; MÄCKE, Helmut R ; MÄLLER-BRAND, Jan ; WALTER, Martin AClinical cancer research, 2007-11, Vol.13 (22), p.6696-6702 [Periódico revisado por pares]Philadelphia, PA: American Association for Cancer ResearchTexto completo disponível |
| 2 |
Material Type: Artigo
|
|
Communication skills training in oncology: a position paper based on a consensus meeting among European experts in 2009Stiefel, F. ; Barth, J. ; Bensing, J. ; Fallowfield, L. ; Jost, L. ; Razavi, D. ; Kiss, A.Annals of oncology, 2010-02, Vol.21 (2), p.204-207 [Periódico revisado por pares]Oxford: Elsevier LtdTexto completo disponível |
| 3 |
Material Type: Artigo
|
|
Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06)Rochlitz, C. ; Ruhstaller, T. ; Lerch, S. ; Spirig, C. ; Huober, J. ; Suter, T. ; Bühlmann, M. ; Fehr, M. ; Schönenberger, A. ; von Moos, R. ; Winterhalder, R. ; Rauch, D. ; Müller, A. ; Mannhart-Harms, M. ; Herrmann, R. ; Cliffe, B. ; Mayer, M. ; Zaman, K.Annals of oncology, 2011-01, Vol.22 (1), p.80-85 [Periódico revisado por pares]Oxford: Elsevier LtdTexto completo disponível |
| 4 |
Material Type: Artigo
|
|
SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancerBOULAY, J-L ; MILD, G ; LOWY, A ; REUTER, J ; LAGRANGE, M ; TERRACCIANO, L ; LAFFER, U ; HERRMANN, R ; ROCHLITZ, CBritish journal of cancer, 2002-09, Vol.87 (6), p.630-634 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |
| 5 |
Material Type: Artigo
|
|
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?Regan, M.M. ; Pagani, O. ; Walley, B. ; Torrisi, R. ; Perez, E.A. ; Francis, P. ; Fleming, G.F. ; Price, K.N. ; Thürlimann, B. ; Maibach, R. ; Castiglione-Gertsch, M. ; Coates, A.S. ; Goldhirsch, A. ; Gelber, R.D.Annals of oncology, 2008-07, Vol.19 (7), p.1231-1241 [Periódico revisado por pares]Oxford: Elsevier LtdTexto completo disponível |
| 6 |
Material Type: Artigo
|
|
MDR1 expression correlates with mutant p53 expression in colorectal cancer metastasesDE KANT, E ; HEIDE, I ; THIEDE, C ; HERRMANN, R ; ROCHLITZ, C. FJournal of cancer research and clinical oncology, 1996, Vol.122 (11), p.671-675 [Periódico revisado por pares]Berlin: SpringerTexto completo disponível |
| 7 |
Material Type: Artigo
|
|
Cancer gene and immunotherapy : recent developmentsJANTSCHEFF, P ; HERRMANN, R ; ROCHLITZ, CCancer Immunology, Immunotherapy, 1999-07, Vol.16 (2), p.78-85 [Periódico revisado por pares]Heidelberg: SpringerTexto completo disponível |
| 8 |
Material Type: Artigo
|
|
Gene therapy with cytokine-transfected xenogenic cells (Vero-IL-2) in patients with metastatic solid tumors : mechanism(s) of elimination of the transgene-carrying cellsJANTSCHEFF, P ; HERRMANN, R ; SPAGNOLI, G ; REUTER, J ; MEHTALI, M ; COURTNEY, M ; ROCHLITZ, CCancer Immunology, Immunotherapy, 1999-09, Vol.48 (6), p.321-330 [Periódico revisado por pares]Berlin: SpringerTexto completo disponível |
| 9 |
Material Type: Artigo
|
|
TREATMENT OF NEUTROPENIA IN FELTYS SYNDROME WITH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR - HEMATOLOGICAL RESPONSE ACCOMPANIED BY PULMONARY COMPLICATIONS WITH LETHAL OUTCOMEGARIBAI, AR ; ROCHLITZ, C ; RIEWALD, M ; OERTEL, J ; HUHN, DAnnals of hematology, 1992-11, Vol.65 (5), p.232-235 [Periódico revisado por pares]NEW YORK: Springer NatureTexto completo disponível |
Personalize Seus Resultados
Refine Search Results
Expandir Meus Resultados
Refinar Meus Resultados
Assunto
- Antineoplastic Agents (8)
- Oncology (8)
- Female (5)
- Male (4)
- Middle Aged (4)
- Tumors (3)
- Chemotherapy (3)
- Aged (3)
- Breast Neoplasms - Drug Therapy (2)
- Animals (2)
- Chemotherapy, Adjuvant (2)
- Colorectal Neoplasms - Genetics (2)
- Colorectal Cancer (2)
- Adult (2)
-
Mais opções
Data de Publicação
- Antes de1992 (1)
- 1992Até1995 (1)
- 1996Até1998 (1)
- 1999Até2002 (3)
- Após 2002 (4)
-
Mais opções
Base de Dados/Biblioteca
- Science Citation Index Expanded (Web of Science) (9)
- Journals@Ovid Full Text (6)
- EBSCO_MEDLINE Complete（医学期刊全文数据库） (5)
- EZB Electronic Journals Library (5)
- Springer Nature - Springer Journals All 2022 (4)
- SpringerLink (4)
- Oxford University Press:Jisc Collections:Medicine Collection:2018 (3)
- Oxford Journals (3)
- Springer Open Access Journals (3)
- ScienceDirect (3)
- HighWire Press (Free Journals) (2)
- Open Access: PubMed Central (2)
- Open Access: Nature Open Access (1)
- Academic Search Premier (EB_SDU_P3) (1)
- Springer Nature - Connect here FIRST to enable access (1)
- Publisher or Other Site (1)
- Open Access: Freely Accessible Journals by multiple vendors (1)
- American Association for Cancer Research (1)
-
Mais opções
Nome da Publicação
- Annals Of Oncology (3)
- Cancer Immunology, Immunotherapy (2)
- Cancer Immunology Immunotherapy (1)
- Clinical Cancer Research (1)
- Cancer Immunology And Immunotherapy (1)
- Cancer Immunology, Immunotherapy : Cii (1)
- British Journal Of Cancer (1)
- Medical Oncology (1)
- Annals Of Hematology (1)
- Journal Of Cancer Research And Clinical Oncology (1)
-
Mais opções
Página Inicial
RSS
Feed
Políticas
Fale Conosco-
Realização:
Logos de Redes Sociais: 